USING THE POWER OF THE COMMUNITY TO MEET OUR GOAL OF PROVING THE BENEFIT OF CANNABIS BASED MEDICATIONS FOR THE TREATMENT OF THE MOST CHALLENGING ILLNESS OF OUR TIME.
1. Prevalence and Impact: Research is vital due to the high prevalence of breast and pancreatic cancer, impacting a large number of people.
2. Early Detection and Treatment: It aims to develop better early detection methods and more effective, targeted therapies, potentially increasing survival rates.
3. Personalized Medicine: Research can lead to personalized treatment plans, improving outcomes by tailoring therapies to an individual’s genetics.
4. Global Health Significance: Breakthroughs can have a global impact, as cancer is a leading cause of death worldwide.
5. Economic and Social Benefits: Advancements in cancer research can alleviate economic burdens, enhance patient quality of life, and receive support from patient advocacy groups.
1. Patient Access and Safety: Prioritizing research on known efficacious cannabis-based medications ensures safe and accessible treatments.
2. No Challenge to Pharma: Pharmaceutical companies have mostly rejected cannabis research due to difficulty in patent protections.
3. Cost-Efficiency: Studying existing medications is often more cost-effective especially for OTC products.
4. Policy and Legalization Impact: Positive research outcomes influence regulatory decisions and cannabis legalization.
5. Healthcare Equity: Focusing on established treatments promotes equitable access to medical cannabis.
1. Cutting-Edge Innovation: Israel’s thriving healthcare technology sector offer access to cutting-edge R&D and medical advancements.
2. Robust Pharmaceutical Industry: Israel’s history of pharmaceutical contributions to groundbreaking research and drug development.
3. Data-Driven Expertise: Proficiency in data utilization enhances research capabilities, especially in personalized medicine.
4. Global Collaboration Hub: Israel’s eagerness to collaborate fosters partnerships for solving critical health challenges.
5. Ethical and Credible Environment: Well-regulated framework ensures ethical practices and safety, enhancing the credibility of clinical studies.
THC AND THE ENDOCANNABINOID SYSTEM WERE DISCOVERED IN ISRAEL BY PROFESSOR RAPHAEL MECHOULAM, THE PROGRESSIVE HEALTHCARE SYSTEM HAS ALLOWED FOR MORE CANNABIS CLINICAL STUDIES PER CAPITA THAN ANYWHERE ELSE IN THE WORLD!